Insulin resistance predicts early cardiovascular morbidity in men without diabetes mellitus, with effect modification by physical activity

European Journal of Preventive Cardiology

Volumn 22, Issue 7, 2015, Pages 940-949

  Hellgren, Margareta I ^a   Daka, Bledar ^a   Jansson, Per Anders ^b   Lindblad, Ulf ^a   Larsson, Charlotte A ^a,c  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c LUND UNIVERSITY   (Sweden)

Author keywords

cardiovascular disease; Insulin resistance; physical activity; prospective cohort study

Indexed keywords

INSULIN; BIOLOGICAL MARKER;

ADULT; AGED; ALCOHOL CONSUMPTION; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; FEMALE; FOLLOW UP; HOSPITAL PATIENT; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIFESTYLE; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL EDUCATION; MEDICAL EXAMINATION; MEDICAL INFORMATION; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; SMOKING; BLOOD; CARDIOVASCULAR DISEASES; GLUCOSE TOLERANCE TEST; MIDDLE AGED; MORTALITY; MOTOR ACTIVITY; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; PROTECTION; REGISTER; RISK ASSESSMENT; RISK FACTOR; SEDENTARY LIFESTYLE; SEX DIFFERENCE; SWEDEN; TIME FACTOR;

ADULT; AGED; BIOMARKERS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; MOTOR ACTIVITY; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PROTECTIVE FACTORS; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SEDENTARY LIFESTYLE; SEX FACTORS; SWEDEN; TIME FACTORS;

EID: 84930607831     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/2047487314537917     Document Type: Article

References (41)

1. Abdul-Ghani MA, Williams K, DeFronzo R, et al. Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose. Diabetes Care. 2006 ; 29: 1613-1618
2. Hu G, Qiao Q, Tuomilehto J, et al. Plasma insulin and cardiovascular mortality in non-diabetic European men and women: a meta-analysis of data from eleven prospective studies. Diabetologia. 2004 ; 47: 1245-1256
3. Di Angelantonio E, Gao P, Khan H, et al. Glycated hemoglobin measurement and prediction of cardiovascular disease. JAMA. 2014 ; 311: 1225-1233
4. van 't Riet E, Rijkelijkhuizen JM, Alssema M, et al. HbA1c is an independent predictor of non-fatal cardiovascular disease in a Caucasian population without diabetes: a 10-year follow-up of the Hoorn Study. Eur J Prev Cardiol. 2012 ; 19: 23-31
5. Hanley AJ, Williams K, Stern MP, et al. Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study. Diabetes Care. 2002 ; 25: 1177-1184
6. Jeppesen J, Hansen TW, Rasmussen S, et al. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study. J Am Coll Cardiol. 2007 ; 49: 2112-2119
7. Gast KB, Tjeerdema N, Stijnen T, et al. Insulin resistance and risk of incident cardiovascular events in adults without diabetes: meta-analysis. PLoS One. 2012 ; 7: e52036 - e52036
8. Rutter MK, Meigs JB, Sullivan LM, et al. Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study. Diabetes. 2005 ; 54: 3252-3257
9. Sarwar N, Sattar N, Gudnason V, et al. Circulating concentrations of insulin markers and coronary heart disease: a quantitative review of 19 Western prospective studies. Eur Heart J. 2007 ; 28: 2491-2497
10. Patel N, Taveira TH, Choudhary G, et al. Fasting serum C-peptide levels predict cardiovascular and overall death in nondiabetic adults. J Am Heart Assoc. 2012 ; 1: e003152 - e003152
11. Schottker B, Muller H, Rothenbacher D, et al. Fasting plasma glucose and HbA1c in cardiovascular risk prediction: a sex-specific comparison in individuals without diabetes mellitus. Diabetologia. 2013 ; 56: 92-100
12. Larsson CA, Gullberg B, Merlo J, et al. Female advantage in AMI mortality is reversed in patients with type 2 diabetes in the Skaraborg Project. Diabetes Care. 2005 ; 28: 2246-2248
13. Norhammar A, Schenck-Gustafsson K. Type 2 diabetes and cardiovascular disease in women. Diabetologia. 2013 ; 56: 1-9
14. Kanaya AM, Grady D, Barrett-Connor E. Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis. Arch Intern Med. 2002 ; 162: 1737-1745
15. Ferrara A, Barrett-Connor EL, Edelstein SL. Hyperinsulinemia does not increase the risk of fatal cardiovascular disease in elderly men or women without diabetes: the Rancho Bernardo Study, 1984-1991. Am J Epidemiol. 1994 ; 140: 857-869
16. Folsom AR, Szklo M, Stevens J, et al. A prospective study of coronary heart disease in relation to fasting insulin, glucose, and diabetes. The Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care. 1997 ; 20: 935-942
17. Blair SN, Kampert JB, Kohl HW, et al. Influences of cardiorespiratory fitness and other precursors on cardiovascular disease and all-cause mortality in men and women. JAMA. 1996 ; 276: 205-210
18. Bijnen FC, Caspersen CJ, Feskens EJ, et al. Physical activity and 10-year mortality from cardiovascular diseases and all causes: The Zutphen Elderly Study. Arch Intern Med. 1998 ; 158: 1499-1505
19. Zethelius B, Gudbjornsdottir S, Eliasson B, et al. Level of physical activity associated with risk of cardiovascular diseases and mortality in patients with type-2 diabetes: report from the Swedish National Diabetes Register. Eur J Prev Cardiol. 2014 ; 21: 244-251
20. Dube JJ, Allison KF, Rousson V, et al. Exercise dose and insulin sensitivity: relevance for diabetes prevention. Med Sci Sports Exerc. 2012 ; 44: 793-799
21. Borodulin K, Tuomilehto J, Peltonen M, et al. Association of leisure time physical activity and abdominal obesity with fasting serum insulin and 2-h postchallenge plasma glucose levels. Diabet Med. 2006 ; 23: 1025-1028
22. Church TS, Barlow CE, Earnest CP, et al. Associations between cardiorespiratory fitness and C-reactive protein in men. Arterioscler Thromb Vac Biol. 2002 ; 22: 1869-1876
23. Huai P, Xun H, Reilly KH, et al. Physical activity and risk of hypertension: a meta-analysis of prospective cohort studies. Hypertension. 2013 ; 62: 1021-1026
24. Williams PT, Thompson PD. Walking versus running for hypertension, cholesterol, and diabetes mellitus risk reduction. Arterioscler Thromb Vac Biol. 2013 ; 33: 1085-1091
25. Roberts CK, Hevener AL, Barnard RJ. Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training. Compr Physiol. 2013 ; 3: 1-58
26. Rundek T, Gardener H, Xu Q, et al. Insulin resistance and risk of ischemic stroke among nondiabetic individuals from the northern Manhattan study. Arch Neurol. 2010 ; 67: 1195-1200
27. Larsson CA, Gullberg B, Rastam L, et al. Salivary cortisol differs with age and sex and shows inverse associations with WHR in Swedish women: a cross-sectional study. BMC Endocr Disord. 2009 ; 9: 16-16
28. Report of a WHO Study Group (1985). World Health Organ Tech Rep Ser. 1985 ; 727: 1-113
29. Andersen L, Dinesen B, Jorgensen PN, et al. Enzyme immunoassay for intact human insulin in serum or plasma. Clin Chem. 1993 ; 39: 578-582
30. Haffner SM, Miettinen H, Stern MP. The homeostasis model in the San Antonio Heart Study. Diabetes Care. 1997 ; 20: 1087-1092
31. Laakso M. Cardiovascular disease in type 2 diabetes from population to man to mechanisms: the Kelly West Award Lecture 2008. Diabetes Care. 2010 ; 33: 442-449
32. Austin MA, King MC, Vranizan KM, et al. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation. 1990 ; 82: 495-506
33. Grant PJ. Diabetes mellitus as a prothrombotic condition. J Intern Med. 2007 ; 262: 157-172
34. Bornfeldt KE, Tabas I. Insulin resistance, hyperglycemia, and atherosclerosis. Cell Metab. 2011 ; 14: 575-585
35. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med. 2001 ; 161: 397-405
36. Faerch K, Vaag A, Holst JJ, et al. Natural history of insulin sensitivity and insulin secretion in the progression from normal glucose tolerance to impaired fasting glycemia and impaired glucose tolerance: the Inter99 study. Diabetes Care. 2009 ; 32: 439-444
37. Lempiainen P, Mykkanen L, Pyorala K, et al. Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men. Circulation. 1999 ; 100: 123-128
38. Mosca L, Grundy SM, Judelson D, et al. Guide to Preventive Cardiology for Women. AHA/ACC Scientific Statement Consensus panel statement. Circulation. 1999 ; 99: 2480-2484
39. Eriksson J, Tuominen J, Valle T, et al. Aerobic endurance exercise or circuit-type resistance training for individuals with impaired glucose tolerance?. Horm Metab Res. 1998 ; 30: 37-41
40. Herder C, Peltonen M, Koenig W, et al. Anti-inflammatory effect of lifestyle changes in the Finnish Diabetes Prevention Study. Diabetologia. 2009 ; 52: 433-442
41. Rosén M, Alfredsson L, Hammar N, et al. Attack rate, mortality and case fatality for acute myocardial infarction in Sweden during 1987-95. Results from the national AMI register in Sweden. J Intern Med. 2000 ; 248: 159-164